The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2008, 181, 3464 -3473
Copyright © 2008 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sukhumavasi, W.
Right arrow Articles by Denkers, E. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sukhumavasi, W.
Right arrow Articles by Denkers, E. Y.

TLR Adaptor MyD88 Is Essential for Pathogen Control during Oral Toxoplasma gondii Infection but Not Adaptive Immunity Induced by a Vaccine Strain of the Parasite1

Woraporn Sukhumavasi2,*, Charlotte E. Egan2,*, Amy L. Warren{dagger}, Gregory A. Taylor{ddagger}, Barbara A. Fox§, David J. Bzik§ and Eric Y. Denkers3,*

* Department of Microbiology and Immunology and {dagger} Department of Biomedical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853; {ddagger} Department of Medicine, Department of Molecular Genetics and Microbiology, Department of Immunology, Division of Geriatrics, and Center for the Study of Aging and Human Development, Duke University Medical Center, and Geriatric Research Education and Clinical Center, Veterans Affairs Medical Center, Durham, NC 27705; and § Department of Microbiology and Immunology, Dartmouth Medical School, Lebanon, NH 03756

TLR adaptor MyD88 activation is important in host resistance to Toxoplasma gondii during i.p. infection, but the function of this signaling pathway during oral infection, in which mucosal immunity assumes a predominant role, has not been examined. In this study, we show that MyD88–/– mice fail to control the parasite and succumb within 2 wk of oral infection. Early during infection, T cell IFN-{gamma} production, recruitment of neutrophils and induction of p47 GTPase IGTP (Irgm3) in the intestinal mucosa were dependent upon functional MyD88. Unexpectedly, these responses were MyD88-independent later during acute infection. In particular, CD4+ T cell IFN-{gamma} reached normal levels independently of MyD88, despite continued absence of IL-12 in these animals. The i.p. vaccination of MyD88–/– mice with an avirulent T. gondii uracil auxotroph elicited robust IFN-{gamma} responses and protective immunity to challenge with a high virulence T. gondii strain. Our results demonstrate that MyD88 is required to control Toxoplasma infection, but that the parasite can trigger adaptive immunity without the need for this TLR adaptor molecule.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by Grants AI47888 (to E.Y.D.), AI57831 (to G.A.T.) and AI14193 (to D.J.B.) from the Public Health Service, a grant for Veterans Affairs Merit Review (to G.A.T.), and a fellowship from the King Anandamahidol Foundation (to W.S.).

2 W.S. and C.E.E. contributed equally to this study.

3 Address correspondence and reprint requests to Dr. Eric Y. Denkers, Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY 14833. E-mail address: eyd1{at}cornell.edu

4 Abbreviations used in this paper: KO, knockout; STAg, soluble tachyzoite Ag; MLN, mesenteric lymph node; CD62L, CD62 ligand; WT, wild type; DC, dendritic cell.




This article has been cited by other articles:


Home page
Infect. Immun.Home page
J. P. Gigley, B. A. Fox, and D. J. Bzik
Long-Term Immunity to Lethal Acute or Chronic Type II Toxoplasma gondii Infection Is Effectively Induced in Genetically Susceptible C57BL/6 Mice by Immunization with an Attenuated Type I Vaccine Strain
Infect. Immun., December 1, 2009; 77(12): 5380 - 5388.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Cekic, C. R. Casella, C. A. Eaves, A. Matsuzawa, H. Ichijo, and T. C. Mitchell
Selective Activation of the p38 MAPK Pathway by Synthetic Monophosphoryl Lipid A
J. Biol. Chem., November 13, 2009; 284(46): 31982 - 31991.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. P. Gigley, B. A. Fox, and D. J. Bzik
Cell-Mediated Immunity to Toxoplasma gondii Develops Primarily by Local Th1 Host Immune Responses in the Absence of Parasite Replication
J. Immunol., January 15, 2009; 182(2): 1069 - 1078.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2008 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2008 by The American Association of Immunologists, Inc. All rights reserved.